Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Paint The Table -- Ignore unavailable to you. Want to Upgrade?

To: Oral Roberts who wrote (22704)	4/2/2002 2:29:55 AM
From: Libbyt	Respond to of 23786

He usually has a pretty good reason for putting out an alert on a stock I'm sure that statement is true. IMO determining a fair value for this company has to take into consideration their recent FDA approval. I don't think most people understand the significance of obtaining FDA approval, and the effect that will have on reimbursements from various insurance plans for the cost of treatment. I would also think this approval might be an important protection against future medical malpractice liability for a physician or renal dialysis lab who wanted to offer this product for home use. I realize that home dialysis has been accomplished by some patients, but has the equipment been purchased by the patient, or reimbursed by the medical insurance plan? Most dialysis equipment is not "user friendly" and takes a great deal of training to successfully operate. Probably patients who are on dialysis would be considered high risk patients, and IMO the physician who would prescribe this treatment would want to offer the best product available. If this dialysis machine is "user friendly" it would seem that FDA approval might make it a better tool for a dialysis lab to use with specific patients who could be properly trained.